Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo
NCT07889492 is registered in ClinicalTrials.gov with Edesa Biotech Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo
- Lead sponsor
- Edesa Biotech Inc.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 5, 2026
- Completion date
- December 31, 2027
- Enrollment
- 80 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
non-segmental vitiligo (nsv)